Aripiprazole. Fluoxetine is predicted to moderately increase the exposure to Atomoxetine. Fluoxetine is predicted to markedly increase the exposure
fluoxetine), so atomoxetine dose should be reduced by half if these agents are coadministered. Coadministration of atomoxetine and oral or IV
CYP2D6 inhibitors, e.g, paroxetine, fluoxetine, and quinidine, atomoxetine should be initiated at Product Monograph - STRATTERA (atomoxetine
Plasma concentrations of atomoxetine may be increased by drugs that inhibit CYP2D6 (e.g, paroxetine, fluoxetine), so atomoxetine dose
Atomoxetine. Fluoxetine is predicted to markedly increase the exposure to Atomoxetine. Manufacturer advises adjust dose. Severity: Severe. Evidence: Study
Atomoxetine. Fluoxetine is predicted to markedly increase the exposure to Atomoxetine. Manufacturer advises adjust dose. Severity: Severe. Evidence: Study
fluoxetine. 1 interaction. atomoxetine (generic). fluoxetine. Monitor/Modify Tx. atomoxetine fluoxetine. maintain atomoxetine start dose x4wk, then incr.
atomoxetine. Report any atomoxetine is possibly inhibited by fluoxetine, paroxetine; increased risk of cardiovascular side effects with intravenous.
FLUoxetine atomoxetine. Applies to: Prozac (fluoxetine) and Strattera (atomoxetine) FLUoxetine may significantly increase the blood levels of atomoxetine. This can increase side effects such as dizziness, dry mouth, loss of appetite, sleep disturbances, and heart palpitations.
Comments
Not everyone wants to read about fucking and fucking and fucking and fucking and fucking and fucking and fucking and fucking and fucking and fucking.